Review




Structured Review

Addgene inc vhl dna
Vhl Dna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vhl dna/product/Addgene inc
Average 93 stars, based on 6 article reviews
vhl dna - by Bioz Stars, 2026-05
93/100 stars

Images



Similar Products

93
Addgene inc vhl dna
Vhl Dna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vhl dna/product/Addgene inc
Average 93 stars, based on 1 article reviews
vhl dna - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
VectorBuilder GmbH dna plasmid pcmv-mcherry-vhl
Dna Plasmid Pcmv Mcherry Vhl, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna plasmid pcmv-mcherry-vhl/product/VectorBuilder GmbH
Average 90 stars, based on 1 article reviews
dna plasmid pcmv-mcherry-vhl - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GenScript corporation recombinant dna reagent vhl-grna-1
Recombinant Dna Reagent Vhl Grna 1, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant dna reagent vhl-grna-1/product/GenScript corporation
Average 90 stars, based on 1 article reviews
recombinant dna reagent vhl-grna-1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GenScript corporation recombinant dna reagent vhl- grna- 2
Recombinant Dna Reagent Vhl Grna 2, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant dna reagent vhl- grna- 2/product/GenScript corporation
Average 90 stars, based on 1 article reviews
recombinant dna reagent vhl- grna- 2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GenScript corporation recombinant dna reagent vhl-grna-2
Recombinant Dna Reagent Vhl Grna 2, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant dna reagent vhl-grna-2/product/GenScript corporation
Average 90 stars, based on 1 article reviews
recombinant dna reagent vhl-grna-2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Thermo Fisher synthetic dna fragment encoding human vhl with an n-terminal 3 × flag-tag
Synthetic Dna Fragment Encoding Human Vhl With An N Terminal 3 × Flag Tag, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/synthetic dna fragment encoding human vhl with an n-terminal 3 × flag-tag/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
synthetic dna fragment encoding human vhl with an n-terminal 3 × flag-tag - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

92
Addgene inc n a recombinant dna plv h1 shscramble hsynapsin egfp wpre
N A Recombinant Dna Plv H1 Shscramble Hsynapsin Egfp Wpre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n a recombinant dna plv h1 shscramble hsynapsin egfp wpre/product/Addgene inc
Average 92 stars, based on 1 article reviews
n a recombinant dna plv h1 shscramble hsynapsin egfp wpre - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
Addgene inc recombinant dna reagent pgal vhl mcherry pmid
Recombinant Dna Reagent Pgal Vhl Mcherry Pmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant dna reagent pgal vhl mcherry pmid/product/Addgene inc
Average 93 stars, based on 1 article reviews
recombinant dna reagent pgal vhl mcherry pmid - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Addgene inc annealed dna oligonucleotides targeting vhl
( A ) Volcano plot of 61 mature miRNAs for which there were significant differences in expression between 8 pairs of <t>VHL−</t> and VHL+ ccRCC tissue samples as assessed by microarray analysis. ( B and C ) qRT-PCR analysis of expression levels of representative downregulated mature miRNAs and corresponding upregulated precursor miRNAs in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( D ) mRNA levels of miRNA biogenesis components in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( E ) Representative immunoblots and quantification of protein levels of miRNA biogenesis components in VHL− ccRCCs ( n = 12) compared with VHL+ ccRCCs ( n = 12). ( F ) Dicer mRNA levels in VHL− ccRCCs ( n = 36) and VHL+ ccRCCs ( n = 36) compared to their corresponding adjacent normal tissues ( n = 36 for both groups). ( G ) Representative immunoblots and quantification of Dicer protein levels in VHL-deficient and pVHL-restored 786-O cells. ( H ) Dicer mRNA levels in VHL-deficient and pVHL-restored 786-O cells. ( I ) Representative immunoblots and quantification of Dicer protein levels in wild-type VHL <t>and</t> <t>VHL-knockdown</t> Caki-1 cells. ( J ) Dicer mRNA levels in wild-type VHL and VHL-knockdown Caki-1 cells. VHL+ denotes wild-type VHL, and VHL− denotes VHL-deficient. Data are presented as mean ± SEM ( n ≥ 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (Student's t -test).
Annealed Dna Oligonucleotides Targeting Vhl, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/annealed dna oligonucleotides targeting vhl/product/Addgene inc
Average 90 stars, based on 1 article reviews
annealed dna oligonucleotides targeting vhl - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Empire Genomics vhl bac dna probe labeled by spectrumorange
( A ) Volcano plot of 61 mature miRNAs for which there were significant differences in expression between 8 pairs of <t>VHL−</t> and VHL+ ccRCC tissue samples as assessed by microarray analysis. ( B and C ) qRT-PCR analysis of expression levels of representative downregulated mature miRNAs and corresponding upregulated precursor miRNAs in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( D ) mRNA levels of miRNA biogenesis components in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( E ) Representative immunoblots and quantification of protein levels of miRNA biogenesis components in VHL− ccRCCs ( n = 12) compared with VHL+ ccRCCs ( n = 12). ( F ) Dicer mRNA levels in VHL− ccRCCs ( n = 36) and VHL+ ccRCCs ( n = 36) compared to their corresponding adjacent normal tissues ( n = 36 for both groups). ( G ) Representative immunoblots and quantification of Dicer protein levels in VHL-deficient and pVHL-restored 786-O cells. ( H ) Dicer mRNA levels in VHL-deficient and pVHL-restored 786-O cells. ( I ) Representative immunoblots and quantification of Dicer protein levels in wild-type VHL <t>and</t> <t>VHL-knockdown</t> Caki-1 cells. ( J ) Dicer mRNA levels in wild-type VHL and VHL-knockdown Caki-1 cells. VHL+ denotes wild-type VHL, and VHL− denotes VHL-deficient. Data are presented as mean ± SEM ( n ≥ 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (Student's t -test).
Vhl Bac Dna Probe Labeled By Spectrumorange, supplied by Empire Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vhl bac dna probe labeled by spectrumorange/product/Empire Genomics
Average 90 stars, based on 1 article reviews
vhl bac dna probe labeled by spectrumorange - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Volcano plot of 61 mature miRNAs for which there were significant differences in expression between 8 pairs of VHL− and VHL+ ccRCC tissue samples as assessed by microarray analysis. ( B and C ) qRT-PCR analysis of expression levels of representative downregulated mature miRNAs and corresponding upregulated precursor miRNAs in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( D ) mRNA levels of miRNA biogenesis components in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( E ) Representative immunoblots and quantification of protein levels of miRNA biogenesis components in VHL− ccRCCs ( n = 12) compared with VHL+ ccRCCs ( n = 12). ( F ) Dicer mRNA levels in VHL− ccRCCs ( n = 36) and VHL+ ccRCCs ( n = 36) compared to their corresponding adjacent normal tissues ( n = 36 for both groups). ( G ) Representative immunoblots and quantification of Dicer protein levels in VHL-deficient and pVHL-restored 786-O cells. ( H ) Dicer mRNA levels in VHL-deficient and pVHL-restored 786-O cells. ( I ) Representative immunoblots and quantification of Dicer protein levels in wild-type VHL and VHL-knockdown Caki-1 cells. ( J ) Dicer mRNA levels in wild-type VHL and VHL-knockdown Caki-1 cells. VHL+ denotes wild-type VHL, and VHL− denotes VHL-deficient. Data are presented as mean ± SEM ( n ≥ 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (Student's t -test).

Journal: Oncotarget

Article Title: Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α

doi: 10.18632/oncotarget.7807

Figure Lengend Snippet: ( A ) Volcano plot of 61 mature miRNAs for which there were significant differences in expression between 8 pairs of VHL− and VHL+ ccRCC tissue samples as assessed by microarray analysis. ( B and C ) qRT-PCR analysis of expression levels of representative downregulated mature miRNAs and corresponding upregulated precursor miRNAs in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( D ) mRNA levels of miRNA biogenesis components in VHL− ccRCCs ( n = 36) compared to VHL+ ccRCCs ( n = 36). ( E ) Representative immunoblots and quantification of protein levels of miRNA biogenesis components in VHL− ccRCCs ( n = 12) compared with VHL+ ccRCCs ( n = 12). ( F ) Dicer mRNA levels in VHL− ccRCCs ( n = 36) and VHL+ ccRCCs ( n = 36) compared to their corresponding adjacent normal tissues ( n = 36 for both groups). ( G ) Representative immunoblots and quantification of Dicer protein levels in VHL-deficient and pVHL-restored 786-O cells. ( H ) Dicer mRNA levels in VHL-deficient and pVHL-restored 786-O cells. ( I ) Representative immunoblots and quantification of Dicer protein levels in wild-type VHL and VHL-knockdown Caki-1 cells. ( J ) Dicer mRNA levels in wild-type VHL and VHL-knockdown Caki-1 cells. VHL+ denotes wild-type VHL, and VHL− denotes VHL-deficient. Data are presented as mean ± SEM ( n ≥ 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (Student's t -test).

Article Snippet: For knockdown of VHL, annealed DNA oligonucleotides targeting VHL were cloned into a pLVTHM lentiviral vector (Addgene).

Techniques: Expressing, Microarray, Quantitative RT-PCR, Western Blot, Knockdown

( A ) Schematic representation of the potential binding site of miR-182-5p in the HIF-2α 3′-UTR and its wild type (WT) or mutated (MUT) sequence within the luciferase reporter vector. ( B and C ) Levels of mature miR-182-5p and precursor miR-182-5p after Dicer ectopic expression (Dicer ORF) in VHL wild-type and VHL knockdown Caki-1 cells. ( D ) Association between HIF-2α mRNA levels and miR-182-5p levels in ccRCCs ( n = 48). ( E ) Representative immunoblots and quantification of HIF-2α protein levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in OS-RC-2 cells. ( F and G ) HIF-2α mRNA levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in OS-RC-2 cells. ( H ) Representative immunoblots and quantification of HIF-2α protein levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in 786-O cells. ( I and J ) HIF-2α mRNA levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in 786-O cells. ( K ) Luciferase activity in OS-RC-2 and 786-O cells transfected with HIF-2α 3′-UTR luciferase reporter vectors with intact or mutated seed sequences in the presence of miR-182-5p mimics or NC, respectively. ( L ) Luciferase activity in OS-RC-2 and 786-O cells transfected with HIF-2α 3′-UTR luciferase reporter vectors with intact or mutated seed sequences in the presence of Dicer ORF or Empty vector, respectively. ORF = open reading frame. Data are presented as mean ± SEM ( n ≥ 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (Student's t -test).

Journal: Oncotarget

Article Title: Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α

doi: 10.18632/oncotarget.7807

Figure Lengend Snippet: ( A ) Schematic representation of the potential binding site of miR-182-5p in the HIF-2α 3′-UTR and its wild type (WT) or mutated (MUT) sequence within the luciferase reporter vector. ( B and C ) Levels of mature miR-182-5p and precursor miR-182-5p after Dicer ectopic expression (Dicer ORF) in VHL wild-type and VHL knockdown Caki-1 cells. ( D ) Association between HIF-2α mRNA levels and miR-182-5p levels in ccRCCs ( n = 48). ( E ) Representative immunoblots and quantification of HIF-2α protein levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in OS-RC-2 cells. ( F and G ) HIF-2α mRNA levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in OS-RC-2 cells. ( H ) Representative immunoblots and quantification of HIF-2α protein levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in 786-O cells. ( I and J ) HIF-2α mRNA levels after miR-182-5p ectopic expression (mimic miR-182-5p) or miR-182-5p inhibition (inhibitor miR-182-5p) in 786-O cells. ( K ) Luciferase activity in OS-RC-2 and 786-O cells transfected with HIF-2α 3′-UTR luciferase reporter vectors with intact or mutated seed sequences in the presence of miR-182-5p mimics or NC, respectively. ( L ) Luciferase activity in OS-RC-2 and 786-O cells transfected with HIF-2α 3′-UTR luciferase reporter vectors with intact or mutated seed sequences in the presence of Dicer ORF or Empty vector, respectively. ORF = open reading frame. Data are presented as mean ± SEM ( n ≥ 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (Student's t -test).

Article Snippet: For knockdown of VHL, annealed DNA oligonucleotides targeting VHL were cloned into a pLVTHM lentiviral vector (Addgene).

Techniques: Binding Assay, Sequencing, Luciferase, Plasmid Preparation, Expressing, Knockdown, Western Blot, Inhibition, Activity Assay, Transfection